Table 1

Clinical details of patients with central nervous system involvement

Age rangeGenderLocalisationAccompanying haematological diseaseSurvival (month)
35–40FemaleNasopharynxW/simultaneous diagnosis of AML28/dead
5–10MaleParapharynxW/subsequent diagnosis of AML52/alive
15–18MaleSkinW/previous diagnosis of MDS4/dead
30–35MaleBrainW/previous diagnosis of AML36/alive
5–10MaleLymph node and pericardiumW/simultaneous diagnosis of AML13/alive
  • AML, acute myeloid leukaemia; MDS, myelodysplastic syndrome; w, with.